{{Rsnum
|rsid=7120482
|Chromosome=11
|position=93058934
|Orientation=plus
|GMAF=0.1648
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 13.3 | 36.3 | 50.4
| HCB | 0.0 | 5.1 | 94.9
| JPT | 0.0 | 1.8 | 98.2
| YRI | 0.0 | 9.5 | 90.5
| ASW | 0.0 | 14.0 | 86.0
| CHB | 0.0 | 5.1 | 94.9
| CHD | 0.0 | 0.9 | 99.1
| GIH | 5.0 | 23.8 | 71.3
| LWK | 0.9 | 19.1 | 80.0
| MEX | 3.4 | 31.0 | 65.5
| MKK | 3.2 | 25.0 | 71.8
| TSI | 6.9 | 45.1 | 48.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23719583
  |Trait=Adverse response to radiation therapy
  |Title=Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.
  |RiskAllele=
  |Pval=5E-8
  |OR=3.10
  |ORtxt=[1.7-5.6]
  }}

{{on chip | Affy GenomeWide 6}}